REFERENCES


Gene Name Pubmed ID Classification Sample Location Remark
TFPI2 20208141MethylationPathology Archives of the University Medical Center Groningen (UMCG).Methylation frequency of TFP12 increases with severity of the cervical lesion.  
TFPI2 19225617Methylation-Methylation of two CpG island clusters located in promoter of tissue factor pathway inhibitor 2 (TFPI2) gene are highly correalted with the incidence of invasive cervical cancer.  
TFPI2 16434596MethylationDakar, SenegalThis gene has been found to be hypermethylated in in a high proportion of invasive cervical cancer clinical samples (86.4%) and therefore has been suggested as a therapeutic target  
TFPI2 19843677MethylationUniversity Medical Center, Groningen.Promoter methylation of this is gene is more frequently in cervical cancers than normal cells (P=0.001)  
TFPI2 18181097MethylationJohns Hopkins Hospital.Methylation of this gene was detected in 9(23.1%) of 39 HSIL Pap tests compared with 2(3.3%) of 60 combined NILM/LSIL Pap tests.